Skip to main content

1 Result(s)

within Clovis Almeida Silva Remove this filter

and

  1. No Access

    Article

    Anti-adalimumab antibodies kinetics: an early guide for juvenile idiopathic arthritis (JIA) switching

    To assess the longitudinal production of anti-adalimumab antibody (AAA) and baseline risk factors for this antibody development in juvenile idiopathic arthritis (JIA) patients initiating adalimumab (ADA).

    Juliana Barbosa Brunelli, Clovis Almeida Silva… in Clinical Rheumatology (2020)